SCHEMBL19786513

SCHEMBL19786513

c1ccc(-n2c3ccccc3c3c4c5ccc6ccccc6c5n(-c5ccccc5)c4c4ccccc4c32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
ATM Q13315 1/20 0.47
SIGMAR1 Q99720 1/20 0.36
HPRT1 P00492 1/20 0.35
ALDH1A1 P00352 4/20 0.34
TSHR P16473 2/20 0.34
MAPK8 P45983 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
IL1R1 P14778 1/20 0.34
GLA P06280 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
CYP2A6 P11509 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPK9 P45984 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25098797 0.93 KDM4E (0.43) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL21109304 0.92 KDM4E (0.48) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL19786668 0.92 KDM4E (0.40) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL17989775 0.89 L3MBTL1 (0.50) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL17989782 0.89 KDM4E (0.50) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL17989779 0.89 KDM4E (0.57) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL10061173 0.89 L3MBTL1 (0.61) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL17123119 0.88 L3MBTL1 (0.42) KDM4EL3MBTL1ATMSIGMAR1HPRT1
SCHEMBL19786521 0.88 ALOX12 (0.41) KDM4EL3MBTL1ATMCYP1A2HSD17B10
SCHEMBL20311899 0.88 L3MBTL1 (0.47) KDM4EL3MBTL1ATMSIGMAR1HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 KDM4E 442/4885L3MBTL1 1707/4885ATM 3467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.